Dr. Ajinkya Ramesh Kulkarni, MD

Dr. Kulkarni practices at Bayhealth Hospital, Sussex Campus in Milford, Delaware, part of Bayhealth Medical Center.

Dr. Kulkarni's NPI, 1962997668, was assigned on June 25, 2018. Dr. Kulkarni holds Delaware license C1-0026810.

Dr. Kulkarni's primary practice is Bayhealth Hospital, Sussex Campus, at 100 Wellness Way, Milford, DE 19963 in Sussex County. The practice phone is (302) 422-3311.

Dr. Kulkarni's primary practice is Bayhealth Hospital, Sussex Campus in Milford, Delaware, part of Bayhealth Medical Center. Dr. Kulkarni is also affiliated with Beebe Healthcare. The medical group on file is Bayhealth. Dmand AI also links Dr. Kulkarni to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kulkarni practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kulkarni's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kulkarni is licensed in Delaware.

CMS data shows 235 Medicare services from Dr. Kulkarni across 5 procedure codes in 2024, for 161 Medicare patients. Medicare paid $20,250 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 161 Medicare patients who saw Dr. Kulkarni in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kulkarni's median patient age at 75, with 52% women.

In 2024, Dr. Kulkarni wrote 139 Medicare Part D claims for 53 patients. 71% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $55 in total drug cost. In 2020, CMS named 72 claims across 3 drugs.

Dr. Kulkarni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kulkarni as offering telehealth.

CMS Open Payments shows 45 general payments to Dr. Kulkarni from 17 drug and device companies from 2020 to 2024. Food and beverage make up the largest share, 89% of the total. Genentech, Inc. paid the most, $298.